Introduction
Progesterone plays an indispensable role in preparing the uterine endometrium for implantation and maintenance of pregnancy in many mammals, including primates. The idea that oestrogen is probably not required for implantation and maintenance of early pregnancy in primates (including the human) stems from the observation that rhesus monkeys ovariectomized within 2-6 days of ovulation or with corpus luteum excision on Day 5 or 6 after ovulation continue pregnancy if treated with progesterone alone (Meyer et al, 1969) . Bosu & Johansson (1975) , however, observed that out of 6 ovariectomized monkeys, progesterone treatment maintained pregnancy in only one animal. Several antioestrogens effective in inhibiting implantation in the rat have also been shown to block pregnancy in the rhesus monkey (Morris et al, 1967) . Most of these compounds have pronounced oestrogenic activity as well as antioestrogenic activity. Moreover, these compounds were given immediately after mating and so an effect on ovum/blastocyst survival or maturation cannot be discounted.
Implantation occurs between Days 7 and 9 after ovulation in the macaque (Heuser & Streeter, 1941) and about Days 6-7 in the human (O'Rahilly, 1973) . Patterns of circulating oestradiol and total oestrogen during the perimplantation period have been described, for the marmoset (Hearn et al, 1978) , rhesus monkey (Anand Kumar et al, 1980) , bonnet monkey (Murty et al, 1980) , chim¬ panzee (Hendrickx & Enders, 1980) and the human (Thomas et al, 1973) . Generally the periimplantation concentration of serum oestradiol is higher in the fertile than in the infertile cycle. Although the role of this oestrogen remains unclear, the high concentrations of oestradiol and those of progesterone are used as one of the markers of pregnancy establishment in the non-human primate (Atkinson et al, 1975) .
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We have investigated whether oestrogen is required for the establishment of pregnancy in the bonnet monkey by using a relatively pure antioestrogen, tamoxifen, to deprive the uterus of oestro¬ genic support at the appropriate time. A preliminary report on the usefulness of tamoxifen in studying oestrogen requirement in early pregnancy in primates has been made (Ravindranath & Moudgal, 1986) .
Materials and Methods
Animals and husbandry. The experiments described herein required the use of a standardized primate breeding colony whose reproductive endocrinology was well established. The south Indian bonnet monkeys (Macaca radiata) were maintained under standard husbandry conditions as described earlier (Prahalada et a!, 1975 (1975) . The serum samples to which an internal standard of tritiated steroid had been added were extracted with diethyl ether. The extracted steroid was measured in duplicate in a liquid-phase system comprising tritiated steroid antigen and antiserum to steroid-BSA conjugate. Dextran-coated charcoal was used to adsorb unbound steroid. The oestradiol assay had an intra-assay coefficient of variation of 12-5% and a sensitivity of 001 ng/ml. The oestradiol antiserum showed a cross-reaction of 10% with oestrone and <1% with oestriol and testosterone.
The progesterone assay had an intra-assay coefficient of variation of 8% and a sensitivity of 001 ng/ml.
The progesterone antiserum showed a cross-reaction of 3% with 17a-hydroxyprogesterone and 5% with 20a-dihydroprogesterone.
Radioimmunoassay used for determining chorionic gonadotrophin in fertile cycles of bonnet monkeys was according to the method described by Jagannadha Rao et a! (1984) . This consisted of incubating serum samples and hCG standards (range from 100 pg to 100 ng) and 125I-labelled hCG with a rabbit antiserum to ovine LH ß-subunit for 12 h at room temperature. Bound and free hormone were separated by adding goat anti-rabbit -globulin serum and the radioactivity precipitated was measured in an autogamma spectrometer. The monkey CG in serum samples was expressed as hCG equivalent read from hCG standards used in the assay. The assay had an intra-assay coefficient of variation of 10-8% and a sensitivity of 5 ng/ml. This assay is specific to CG and does not exhibit cross-reactivity with monkey pituitary extract or serum from castrated monkeys (Jagannadha Rao et a!, 1984 (Fig. 1, Group II) ; tamoxifen had no effect on serum oestrogen concentrations (Fig. 1 Table 2 ). no fetal remnants were recovered in the break-through bleeding of any of the 4 monkeys (this is normally to be expected if abortion occurs after Day 50), it was felt that establishment of pregnancy was prevented in these monkeys by tamoxifen treatment, as it was in those of Group II, but menstruation was delayed because of the effect of MPA.
In the progesterone-treated animals (Group IV), 2 out of 11 monkeys continued pregnancy to term. Of the remaining 9, one showed an early end of the cycle (Day 24) and the others showed vaginal bleeding between Days 36 and 48. Five of these monkeys were CG-positive on Day 28. The remaining 3, which were CG-negative, also showed delay in bleeding and this could be due to continuous administration of progesterone.
Effect of tamoxifen on serum oestrogen and progesterone profiles
The serum oestrogen concentration of mated monkeys treated with tamoxifen alone (Group II, Fig. 2 ) was significantly higher than that of the control (Group I, Fig. 2 ) pregnant monkeys (P < 001). Treatment with progesterone, however, significantly reduced serum oestrogen concen¬ tration (Group IV, Fig. 2 ; < 0-01). Treatment with MPA also resulted in reduction in serum oestrogen values but this effect was much less than that produced by progesterone (compare Groups III & IV, Fig. 2) .
The serum progesterone concentrations of the tamoxifen-treated mated monkeys were not significantly different from those of the control pregnant monkeys (Groups I & II, Fig. 2 (Table 4) . The hormone concentrations in these females are shown in Fig. 3 .
The ability of tamoxifen to promote progesterone production when given at the daily dose of 15 mg for 13 days (Fig. 2) was abolished by reducing the daily dose to 2-5 mg (Fig. 3 , Group II and/or shortening the duration of treatment to 5 days (Fig. 3, Groups III & IV) . The progesterone profile beyond Day 24 of the cycle after 2-5 mg (13 days) or 7-5 mg (5 days) tamoxifen was signifi¬ cantly different from that observed when 15 mg tamoxifen were given for 13 days (P < 005). The effect of tamoxifen on oestrogen production was also substantially diminished by reducing the dose and/or duration of treatment (compare Fig. 3 Table 2 ). (treatment plus 2 cycles) was normal (with regard to length and hormonal profiles) and mating during the 3rd or 4th post-treatment cycle resulted in most of the females becoming pregnant. Reducing the dosage of tamoxifen exposure to 5 days only (15 mg daily from Days 16 to 20 only) or lowering the daily dosage (2-5 mg daily for 13 days) had no effect on the cycle length of hormonal profile of the post-treatment cycle and all the monkeys became pregnant after mating in subsequent cycles.
Discussion
The functional significance of luteal-phase oestrogen in the primate, particularly that of the pregnant cycle, remains unclear. Besides its own receptor concentration in the uterus, oestrogen is known to regulate that of progesterone (Kreitmann et al, 1979 (Morris et al, 1967) . As far as we are aware, except for one study with marmosets, tamoxifen has not been tested for its antifertility effects in primates. In the marmoset study, 4 out of 6 females treated with 0-2 mg tamoxifen/kg/day for 6 months remained non-pregnant for the duration of treatment (Furr et al, 1979 Tables 3 and 4 shows that tamoxifen is efficient at preventing conception (Table 5) . Exogenous progesterone treatment did not markedly vary the effect.
In the pregnant rhesus monkey the ratio of endometrial nuclear oestrone/oestradiol receptors increases from 0-50 on Day 5 to 0-80 on Day 18 and to 2-45 on Day 24 of a fertile cycle (KreitmannGimbal et al, 1981) . Assuming that the bonnet monkey also exhibits a uterine oestrogen receptor pattern like that of the rhesus monkey, it was considered desirable to start tamoxifen treatment from Day 16 of the cycle, well before the onset of the increase in nuclear oestrogen receptors. The relatively long half-life of the drug (7-5 days; Fromson et al, 1973) also prompted us to reduce the duration of exposure to 5 days only. Neither of these manipulations affected the overall efficacy of the drug.
Tamoxifen could be promoting luteal function in the bonnet monkey by increasing basal concentrations of LH or antagonizing any natural luteolytic activity oestrogen may exhibit (Karsch et al, 1973) . The luteal tissue is known to have oestrogen receptors although their role in regulating progesterone production remains obscure. Tamoxifen-treated monkeys showed an increase or no change in serum oestrogen concentrations. This increase could be due to tamoxifen affecting catabolism of oestrogen by occupying its receptor sites in the liver. Progesterone treatment brought about a marked suppression in serum oestrogen concentrations, but the mechanism by which this is achieved is not known. Bosu & Johansson (1975) , still have basal values of oestrogen (perhaps adrenal in origin) and these may be adequate to maintain the receptor load once the preovulatory oestrogen induces receptors in the endometrium.
The mechanism by which tamoxifen is expressing its antifertility activity in primates is currently unknown. By delaying the start of tamoxifen administration, any oestrogenic effect it may have on tubai transport is circumvented and the present study also shows that it has no inhibitory effect on ovarian steroid production. The possibility of the drug influencing the uterine microenvironment making it hostile for implantation or for the blastocyst to survive has to be considered.
The present study (1) (Furr et al, 1979) .
